# Avatrombopag on the Treatment of Thrombocytopenia Induced by Chemotherapy of Malignant Tumors

> **NCT04609891** · NA · COMPLETED · sponsor: **Anhui Provincial Cancer Hospital** · enrollment: 74 (actual)

## Conditions studied

- Thrombocytopenia

## Interventions

- **DRUG:** Avatrombopag

## Key facts

- **NCT ID:** NCT04609891
- **Lead sponsor:** Anhui Provincial Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-26
- **Primary completion:** 2021-05-16
- **Final completion:** 2021-05-16
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2022-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04609891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04609891, "Avatrombopag on the Treatment of Thrombocytopenia Induced by Chemotherapy of Malignant Tumors". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04609891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*